Treatment of Hypertension in the UK: Simple as ABCD?

Ezzati M. , Lopez A.D. , Rodgers A. , Vander Hoorn S. , Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–60

Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–13

Collaboration Blood Pressure Lowering Treatment Trialists. Effects of angiotensin converting enzyme inhibitors, calcium antagonists and other blood pressure lowering drugs on mortality and major cardiovascular morbidity. Lancet 2000; 356: 1955–64

Primatesta P. , Brookes M. , Poulter N.R. Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001; 38: 827–32

He F.J. , MacGregor G.A. Cost of poor blood pressure control in the UK: 62,000 unnecessary deaths per year. J Hum Hypertension 2003; 17: 455–7

Walley T. , Duggan A.K. , Haycox A.R. , Niziol C.J. Treatment for newly diagnosed hypertension: patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med 2003; 96: 525–31

Williams B. Treating hypertension: it is not how you start but where you end that matters. J Hypertension 2003; 21: 211–13

Brown M.J. , Cruickshank J.K. , Dominiczak A.F. , MacGregor G. , Poulter N.R. , Russell G.I. , Thom S. , Williams B. Better blood pressure control: how to combine drugs. J Hum Hypertension 2003; 17: 81–6.